3 Covid Vaccine Stocks with Growth Potential and 3 to Avoid

Even with recent vaccine announcements, investors still have an opportunity to profit from Covid vaccine stocks. Moderna’s (MRNA) recent announcement of a Covid-19 vaccine which demonstrates 94.5% efficacy has driven the share price higher while also pressuring Pfizer (PFE) and BioNTech (BNTX), who jumped similar...
Read More